Evidence map›Paper›PMID 30664613›Full record

SynthesisMedical care2019

Measuring and Analyzing Length of Stay in Critical Care Trials.

Michael O Harhay, Sarah J Ratcliffe, Dylan S Small, Leah H Suttner, Michael J Crowther, Scott D Halpern

Abstract readSystematic Review
In one paragraph

Synthesis in Medical care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The times are changing: A primer on novel clinical trial designs and endpoints in critical care research.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael O HarhayDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine.
Sarah J RatcliffeDepartment of Public Health Sciences, University of Virginia, Division of Biostatistics, Charlottesville, VA.
Dylan S SmallPalliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania, Philadelphia, PA.
Leah H SuttnerDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine.
Michael J CrowtherBiostatistics Research Group, Department of Health Sciences, Centre for Medicine, University of Leicester, Leicester, UK.
Scott D HalpernDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine.

Funding

Semi-parametric joint models for longitudinal and time to event dataR01GM104470 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GUO, WENSHENG, RATCLIFFE, SARAH J · 2013 to 2016
$1.2M
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failureK99HL141678 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2018 to 2019
$214k
Methods to improve the detection of treatment effects in ARDS clinical trialsF31HL127947 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2015 to 2016
$71k
NHLBI NIH HHS F31 HL127947NHLBI NIH HHS K99 HL141678NIGMS NIH HHS R01 GM104470
6 · The paper itself

Abstract

backgroundIn randomized clinical trials among critically ill patients, it is uncertain how choices regarding the measurement and analysis of nonmortal outcomes measured in terms of duration, such as intensive care unit (ICU) length of stay (LOS), affect studies' conclusions.

objectivesAssess the definitions and analytic methods used for ICU LOS analyses in published randomized clinical trials. RESEARCH

designThis is a systematic review and statistical simulation study.

resultsAmong the 80 of 150 trials providing sufficient information regarding the chosen definition of ICU LOS, 3 different start times (ICU admission, trial enrollment/randomization, receipt of intervention) and 2 end times (discharge readiness, actual discharge) were used. In roughly three quarters of these studies, ICU LOS was compared using approaches that did not explicitly account for death, either by ignoring it entirely or stratifying the analyses by survival status. The remaining studies used time-to-event (discharge) models censoring at death or applied a fixed LOS value to patients who died. In statistical simulations, we showed that each analytic approach tested a different question regarding ICU LOS, and that approaches that do not explicitly account for death often produce misleading or ambiguous conclusions when treatments produce small effects on mortality, even if those are not detected as significant in the trial.

conclusionsThere is considerable variability in how ICU LOS is measured and analyzed which impairs the ability to compare results across trials and can produce spurious conclusions. Analyses of duration-based outcomes such as LOS should jointly assess the impact of the intervention on mortality to yield correct interpretations.

Indexed as

Critical CareData AnalysisHospital MortalityHumansIntensive Care UnitsLength of StayRandomized Controlled Trials as Topic

Identifiers

PMID30664613
PMCPMC6635104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.